Lunaphore Technologies S.A.: Lunaphore Announces Formation of New Scientific Advisory Board Lunaphore Technologies SA, a Swiss life-sciences company developing innovative next-generation equipment for cancer research, announces the formation of its Scientific Advisory Board (SAB) with the appointment of two experts in the immuno-oncology (I-O) field to provide strategic advisory support to the company's R&D activities and product portfolio development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210114005435/en/ Dr. Jerome Galon Member of Lunaphore Scientific Advisory Board (Photo: Business Wire) The role of the SAB will be to bring strategic insights that will enable Lunaphore to become leaders in the field of high-dimensional analysis of tissue samples. The SAB will support as well in the establishment of scientific partnerships with key stakeholders for the coming years.